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A 69-year-old male retired factory worker presented with a 3-month history of effort-related angina (Canadian Cardiovascular Society Class II). His father died when he was 52 years old with a suspected myocardial infarction. Medical history includes type 2 diabetes treated with oral agents. His past cardiac history is one of previous coronary angioplasty to the anterior descending and left circumflex coronary artery some 3 years previously, from which he made a good symptomatic recovery. On examination, he was in sinus rhythm and his heart rate was 80 b.p.m. and blood pressure (BP) 120/70 mmHg.

At investigation, his haemoglobin was 14.7 g, glycated haemoglobin (HbA~1C~) 7.5%, total cholesterol 175 mg/dL, low-density lipoprotein 85 mg/dL, and high-density lipoprotein 70 mg/dL. A two-dimensional echocardiography demonstrated well-preserved left ventricular function with an ejection fraction of 54%.

His current treatment was bisoprolol 2.5 mg once daily, amlodipine 5 mg once daily, atorvastatin 20 mg once daily, and aspirin 75 mg once daily.

What further investigations do you require?
===========================================

We performed a coronary computed tomography angiography with fractional flow reserve and identified a new significant lesion in the left anterior descending artery distal to the previous angioplasty and a new lesion in the right coronary artery. Alternatively, we could have performed a non-invasive test of myocardial perfusion.

What should we do next?
=======================

First, we need to optimize his risk factor control by increasing atorvastatin to 40 mg once daily. Second, we need to optimize his antianginal treatment. Beta-blockers should be used with caution in patients with type 2 diabetes, and, as his BP is low, the dose of amlodipine should not be increased. In view of his low BP and high heart rate, ivabradine would be the treatment of choice, starting at ivabradine 5 mg twice daily and increasing to 7.5 mg twice daily for control of his heart rate as well as his angina.

In the event that the symptoms are not controlled by this treatment regime, the addition of trimetazidine or ranolazine could be considered. However, if angina cannot be controlled, the patient should undergo reinvestigation with coronary angiography, with a view to repeat the coronary angioplasty.[@suz198-B1]^,^[@suz198-B2]
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